Drug recall · March 14, 2018
Methylphenidate Hydrochloride Extended-release Tablets recall
Why: Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC 13811-708-10
- Lots / codes
Lots: 170231B, 170232A, 170233A, 170234A
- Quantity
- 19,664 100-bottles
- Company
- Osmotica Pharmaceutical Corp, Marietta, GA
- Distribution
- Nationwide in the USA
- Initiated
- February 28, 2018 · Voluntary: Firm initiated
- Classified
- March 6, 2018
- Reported
- March 14, 2018
- Ended
- May 1, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methylphenidate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.